DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundationMRCS

Ulcerative colitis

Essential points for quick revision.

Synopsis

Diagnose ulcerative colitis, describe its continuous colonic extent and activity, and deliver steroid-sparing medical care with timely surveillance and surgical discussion.

  • Ulcerative colitis is chronic mucosal inflammation beginning in the rectum and extending proximally in a usually continuous pattern; extent can change over time or appear modified by treatment.
  • Bloody diarrhoea, urgency, tenesmus and nocturnal stool are typical, but diagnosis still requires stool infection assessment, endoscopy and histology rather than symptoms alone.
  • Record proctitis, left-sided or extensive disease and quantify activity because topical reach, systemic risk, surveillance and treatment selection all depend on them.

Key red flags

Suspected acute severe colitis requires same-day hospital assessment with gastroenterology and colorectal surgery involvement from admission.

Investigation priorities

01
Stool culture and Clostridioides difficile testingFirst step

Exclude treatable infection at diagnosis and during clinically important flares.

Management branches

CONFIRMEstablish diagnosis and extent

Persistent bloody diarrhoea, urgency or tenesmus raises suspicion of new ulcerative colitis.

  1. Assess haemodynamic and systemic severity first, admitting suspected acute severe disease rather than progressing through a routine outpatient pathway.
  2. Obtain blood and stool tests, including infection assessment, medication and travel history, and examine for abdominal, perianal and extra-intestinal findings.

Key medicines

MesalazineOral and rectal regimen matched to extent, formulation and licensed product instructions.
CorticosteroidTime-limited topical, oral or intravenous induction course selected by severity.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom